Current Good Manufacturing Practice for Finished Pharmaceuticals¶
U.S. Food and Drug Administration. (1978). Current Good Manufacturing Practice for Finished Pharmaceuticals.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Quality Control
- Pharmaceuticals: Good Manufacturing Practice (GMP) batch testing, stability studies, contamination detection, potency assays, dissolution testing, microbial limits testing, finished-product release testing, as codified in the U.S. FDA's (1978) 21 CFR Part 211 regulation governing finished-pharmaceutical manufacturing.
This sourceU.S. Government Printing Office. Federal regulation governing pharmaceutical batch testing, stability studies, potency assays, microbial limits, and finished-product release testing under cGMP.
- Pharmaceuticals: Good Manufacturing Practice (GMP) batch testing, stability studies, contamination detection, potency assays, dissolution testing, microbial limits testing, finished-product release testing, as codified in the U.S. FDA's (1978) 21 CFR Part 211 regulation governing finished-pharmaceutical manufacturing.
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Was it audited? Yes. A second, independent pass read the citation against the article text and recorded a verdict.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:96c62350da9d · see in the full table